Reduced Haloperidol

• UNSPSC Description:

  Reduced Haloperidol (Haloperidol metabolite II) is an antipsychotic compound with neurotransmitter modulating activity. Reduced Haloperidol is commonly used to inhibit schizophrenia and other psychotic disorders. Reduced Haloperidol helps reduce the occurrence of hallucinations and delusions by inhibiting the activity of dopamine receptors.

• Target Antigen:

  Drug Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Assay Protocol:

  https://www.medchemexpress.com/reduced-haloperidol.html

• Smiles:

  FC1=CC=C(C(CCCN2CCC(C3=CC=C(C=C3)Cl)(CC2)O)O)C=C1

• Molecular Weight:

  377.88

• References & Citations:

  [1]Autotaxin is a novel target of micro RNA-101-3p|[2]Lysophosphatidic acid and its receptor LPA1 mediate carrageenan induced inflammatory pain in mice

• Shipping Conditions:

  Room temperature

• CAS Number:

  34104-67-1